4//SEC Filing
O'Brien Kathrine 4
Accession 0000792977-19-000070
CIK 0000792977other
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 4:15 PM ET
Size
9.6 KB
Accession
0000792977-19-000070
Insider Transaction Report
Form 4
O'Brien Kathrine
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-04-10+6,000→ 6,000 totalExercise: $12.92Exp: 2029-04-10→ Common Stock (6,000 underlying) - Award
Stock Option (Right to Buy)
2019-04-10+1,200→ 1,200 totalExercise: $12.92Exp: 2029-04-10→ Common Stock (1,200 underlying) - Award
Common Stock
2019-04-10+564→ 564 total
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the "Issuer"). These shares of Common Stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's Fourth Amended & Restated 2007 Equity Incentive Plan, as amended (the "Plan") that will vest on May 1, 2019; however, delivery of the shares is deferred until the earlier of (a) one year from the date of grant and (b) the date of the director's separation from service to the Issuer.
- [F2]Not applicable.
- [F3]Grant of stock option pursuant to the Plan. This option will vest and become exercisable in twenty-four equal monthly installments over two years from the date of grant.
- [F4]Grant of stock option pursuant to the Plan. This option will vest and become exercisable on May 1, 2019.
Documents
Issuer
AMAG PHARMACEUTICALS INC.
CIK 0000792977
Entity typeother
Related Parties
1- filerCIK 0001754277
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 4:15 PM ET
- Size
- 9.6 KB